The inhibition of Smad6 by cAMP rescued the phosphorylation of Smad1/5 in the bone morphogenic protein signalling cascade, thereby reducing the proliferation of PASMC in both healthy and PAH derived cells. This evidence concerns the gene SMAD1 and pulmonary arterial hypertension.